Publish Ahead of Print

Case Report

Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report
Shuchun Li, Junjun Ma, Xizhou Hong, Minhua Zheng, Shigenori Goto, Rishu Takimoto, Takashi Kamigaki, Lu Zang
A case report of primary anaplastic large cell lymphoma arising from the trachea
Suidan Huang, Thomas S. C. Ng, Xiaoyin Xu, Huai Chen

Editorial

Hot topics in cholangiocarcinoma
Giovanni Brandi
Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?
Caterina Mecca, Valentina Bertaglia, Silvia Novello
Postmastectomy radiation therapy in women with T1–T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial
Fabiana Gregucci, Maria Carmen De Santis, Laura Lozza, Alba Fiorentino
Anti-GD2 CAR T cells could prove transformative for H3-K27M+ diffuse midline gliomas
Koichi Furukawa, Yuhsuke Ohmi, Keiko Furukawa
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study
Giandomenico Roviello, Daniele Generali, Navid Sobhani
Value of magnetic resonance imaging in predicting BRAF mutation in craniopharyngiomas
Mario Giordano, Ismail Zaed
A new paradox for pCR in BRCA mutation carriers
Konstantinos Rounis, Dimitrios Mavroudis
Atezolizumab plus platinum-based regimen and bevacizumab: is it time to consider immunotherapy in a concurrent approach for lung cancer?
Andrea Bianco, Susan F. M. Campbell
CircNT5E/miR-422a: a new circRNA-based ceRNA network in glioblastoma
Deborah Morena, Francesca Picca, Riccardo Taulli
Impact of breast surgery in de novo stage IV breast cancer
Tadahiko Shien
Proton beam radiosurgery: early clinical results
Janet Leon, Jennifer Peterson, Austin Hadley, Laura Vallow, Daniel M. Trifiletti
Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
Shih-Fan Lai, Chiun-Sheng Huang, Sung-Hsin Kuo
Evolving development of multi-parametric normal tissue complication probability model for liver radiotherapy
Chiao-Ling Tsai, Jason Chia-Hsien Cheng
Development and validation of a polygenic hazard score for aggressive prostate cancer identification
Nihal E. Mohamed, Ashutosh K. Tewari, Kamlesh K. Yadav
Circular RNA as a prospective molecular tool for the study of neuroprotection in cerebral ischemia
Svetlana A. Limborska, Ivan B. Filippenkov
The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
Vadim S. Koshkin, Arnab Basu, Petros Grivas
Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial
Danilo Rocco, Luigi Della Gravara, Umberto Malapelle, Giancarlo Troncone, Cesare Gridelli
ARID1A: guardian of normal pancreatic ducts
Karla J. Castellanos, Paul J. Grippo
Prospects for cost-effective lung cancer screening using risk calculators
Marianne Weber, Annette McWilliams, Karen Canfell
Editorial on the integrated multidisciplinary algorithm for the management of spinal metastases
Wen Jie Choy, Kevin Phan, Ralph J. Mobbs
Twist1 activated circRNA-10720 is a new player in hepatocellular carcinoma metastasis
Alfons Navarro
Metastasis suppression and enhancement of anti-tumour immunity by targeting the FSTL1-DIP2A axis
Gopinath M. Sundaram, Shan Quah, Prabha Sampath
Bevacizumab in recurrent glioblastoma
Nina L. Martinez, Jon Glass, Wenyin Shi
The time has come to pull renal cancer’s sweet tooth
Adam Kinnaird, Evangelos D. Michelakis
The updated AJCC/TNM staging system (8th edition) for oral tongue cancer
Kyubo Kim, Dong Jin Lee
Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
Tibor Szarvas, Csilla Olah, Henning Reis
Role of pelvic lymph node dissection in bladder cancer: is it better to do more?
Anthony Dat, Shomik Sengupta
Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?
Stéphane Supiot, Caroline Rousseau
Squaring the circle: sponging microRNAs in gastric cancer
Steven G. Gray
(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas
Leland G. Richardson, Bryan D. Choi, William T. Curry
Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
James A. Bonner, Drexell H. Boggs
Circular RNA YAP1: a new player in gastric cancer
Lorena Verduci, Giovanni Blandino
Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer
Salma Kaochar, Nicholas Mitsiades

Original Article

Effects of ginsenoside Rg3 on apoptosis in A375.S2 melanoma cells
Joo Hyoung Kim, Yong Chan Bae, Jae Woo Lee, June Seok Choi, Seong Hwan Bae
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma
Andrea Ruzzenente, Michela De Angelis, Simone Conci, Tommaso Campagnaro, Giulia Isa, Fabio Bagante, Andrea Ciangherotti, Corrado Pedrazzani, Paola Capelli, Calogero Iacono, Alfredo Guglielmi
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience
Hong Pan, Jing Tao, Mengjia Qian, Wenbin Zhou, Yi Qian, Hui Xie, Shengqi Jing, Tingyu Xu, Xin Zhang, Zuolei Dai, Mingliang You, Yun Liu, Xiaoan Liu, Shui Wang
Circular RNA hsa_circ_0002124 promotes hepatocellular carcinoma cell proliferation through the MAPK pathway
Zhigang Fang, Ruifang Fan, Ying Lu, Yanling Sun, Caihan Zhao, Lingling Liu, Xiangfu Liu
NUMB knockdown enhanced the anti-tumor role of cisplatin on ovarian cancer cells by inhibiting cell proliferation and epithelial-mesenchymal transition
Zhao Liu, Shasha Qi, Yibing Fu, Liang Shen, Mingjiang Li, Jiaju Lu, Xingbo Zhao, Hui Zhang
Risk factors and prediction of postoperative hypoparathyroidism among patients with papillary thyroid carcinoma
Shi-Hang Xue, Zhi-Yu Li, Wei-Zhu Wu
A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells
Xiaolong Li, Yingwen Huang, Pengfei Wang, Wei Song, Qingmei Yao, Qiping Hu, Sufang Zhou
Multiplex fluorescent immunohistochemistry quantitatively analyses microvascular density (MVD) and the roles of TGF-β signalling in orchestrating angiogenesis in colorectal cancer
Lei Yang, Zheng Liu, Tao Wen
Role of PRMT5 in bladder cancer: a comprehensive study
Yingxin Ma, Yucheng Zhong, Weiren Huang
Rapamycin downregulates NKG2D ligands in acute myeloid leukemia cells via an activation of the STAT3 pathway: a potential mechanism for rapamycin-induced immune escape in leukemia
Zhichao Zhu, Yu Bai, Xuzhang Lu, Jun Ding, Chunjian Qi
Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells
Chunzi Gao, Shilong Liu, Yanli Wang, Geqi Cha, Xiangying Xu
STX4 expression is associated with classification, clinical stage and lymphatic metastasis in ovarian cancer
Wenfeng Ye, Dawei Zhu, Bin Xu, Ming Xu, Yingting Liu, Jun Xie, Qi Wang, Jingting Jiang
The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
Peng Peng, Wei Zhang, Dongyan Cao, Jiaxin Yang, Keng Shen
Solamargine inhibits proliferation and promotes apoptosis of CM-319 human chordoma cells through suppression of notch pathway
Junqi Liu, Zhenlin Wang, Cong Xu, Yan Qi, Qiuhang Zhang
Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16
Cheng Gao, Xinqian Wu, Jing Zhai, Jiajia Shen, Shoulin Wang, Lizong Shen
Human cancer cells compensate the genes unfavorable for translation by N6-methyladenosine modification and enhance their translation efficiency
Duan Chu, Lai Wei
Microarray-based differential expression profiling of long noncoding RNAs and messenger RNAs in formalin-fixed paraffin-embedded human papillary thyroid carcinoma samples
Hui-Xian Yan, Jin Du, Jing Fu, Wei Huang, Li-Meng Jia, Pang Ping, Ling Zhao, Ye-Qiong Song, Xiao-Meng Jia, Jing-Tao Dou, Yi-Ming Mu, Fu-Lin Wang, Wen Tian, Zhao-Hui Lyu
BRCA1/2 mutation spectrum in Chinese early-onset breast cancer
Mengjia Shen, Libo Yang, Ting Lei, Lin Xiao, Li Li, Peichuan Zhang, Weiyi Feng, Feng Ye, Hong Bu
miR-1290 inhibits chordoma cell proliferation and invasion by targeting Robo1
Bin Wang, Kai Zhang, Hao Chen, Jian Lu, Guizhong Wu, Huilin Yang, Kangwu Chen

Review Article

Adjuvant treatment in biliary tract cancer
Andrea Palloni, Giorgio Frega, Stefania De Lorenzo, Alessandro Rizzo, Francesca Abbati, Marzia Deserti, Simona Tavolari, Giovanni Brandi
Cholangiocarcinoma: the quest for a second-line systemic treatment
Angélique Vienot, Cindy Neuzillet
The future is now: beyond first line systemic therapy in hepatocellular carcinoma
Iuliana Nenu, Iulia Breaban, Sorana Pascalau, Cristina-Nelida Bora, Horia Stefanescu
Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers
Lorenzo Mulazzani, Margherita Alvisi
Surgical management of hepatocellular carcinoma—Western versus Eastern attitude
Flavia Neri, Lorenzo Maroni, Matteo Ravaioli

Case report

Magnetic susceptibility artefact on MRI mimicking lymphadenopathy: description of a nasopharyngeal carcinoma patient
Feng Zhao, Xiaokai Yu, Jiayan Shen, Xinke Li, Guorong Yao, Xiaoli Sun, Fang Wang, Hua Zhou, Zhongjie Lu, Senxiang Yan

Brief Report

County poverty levels influence genome-wide DNA methylation profiles in African American and European American women
Ping-Ching Hsu, Susan Kadlubar, L. Joseph Su, Daniel Acheampong, Lora J. Rogers, Gail Runnells, Pearl A. McElfish, Mario Schootman